OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Stromal-derived NRG1 enables oncogenic KRAS bypass in pancreas cancer
Jincheng Han, Jiaqian Xu, Yonghong Liu, et al.
Genes & Development (2023) Vol. 37, Iss. 17-18, pp. 818-828
Open Access | Times Cited: 10
Jincheng Han, Jiaqian Xu, Yonghong Liu, et al.
Genes & Development (2023) Vol. 37, Iss. 17-18, pp. 818-828
Open Access | Times Cited: 10
Showing 10 citing articles:
Targeting KRAS in cancer
Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 969-983
Closed Access | Times Cited: 67
Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 969-983
Closed Access | Times Cited: 67
CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy
Keishi Yamashita, Yusuke Kumamoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6003-6003
Open Access | Times Cited: 6
Keishi Yamashita, Yusuke Kumamoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6003-6003
Open Access | Times Cited: 6
Progress of KRAS G12C inhibitors in the treatment of refractory colorectal cancer and strategies for drug resistance response
Peiyuan Yang, Yongchao Li
Investigational New Drugs (2025)
Closed Access
Peiyuan Yang, Yongchao Li
Investigational New Drugs (2025)
Closed Access
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRAS G12D inhibitor in KRAS LUAD
Fernando C. Baltanás, Maximilian Kramer‐Drauberg, Rósula García‐Navas, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
Fernando C. Baltanás, Maximilian Kramer‐Drauberg, Rósula García‐Navas, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
Drugging the Undruggable and beyond: Emerging precision oncology approaches to target acquired resistance to KRAS G12C and KRAS G12D inhibitors
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151688-151688
Closed Access
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151688-151688
Closed Access
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Hope on the Horizon: A Revolution in KRAS Inhibition Is Creating a New Treatment Paradigm for Patients with Pancreatic Cancer
Andrew J. Aguirre, Ben Z. Stanger, Anirban Maitra
Cancer Research (2024) Vol. 84, Iss. 18, pp. 2950-2953
Closed Access | Times Cited: 4
Andrew J. Aguirre, Ben Z. Stanger, Anirban Maitra
Cancer Research (2024) Vol. 84, Iss. 18, pp. 2950-2953
Closed Access | Times Cited: 4
Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer
Hongyan Li, Lina Xu, Hongshun Cao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Hongyan Li, Lina Xu, Hongshun Cao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Challenges and Opportunities in Targeting the Complex Pancreatic Tumor Microenvironment
Jennifer M. Finan, Yifei Guo, Shaun Goodyear, et al.
JCO oncology advances. (2024), Iss. 1
Closed Access | Times Cited: 1
Jennifer M. Finan, Yifei Guo, Shaun Goodyear, et al.
JCO oncology advances. (2024), Iss. 1
Closed Access | Times Cited: 1
Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer
Ofra Novoplansky, Sankar Jagadeeshan, Manu Prasad, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access
Ofra Novoplansky, Sankar Jagadeeshan, Manu Prasad, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access
